Avidity Biosciences (RNA) is down -18.2%, or -$8.44 to $37.96.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNA:
- Avidity Biosciences falls -19.5%
- Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion
- Avidity Biosciences price target raised to $56 from $54 at BofA
- Avidity Biosciences
- Avidity Biosciences’ Del-Zota Shows Promising Data in DMD, Justifying Buy Rating and $56 Price Target